The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and genomic hallmarks of low PSA secretors in metastatic castration-resistant prostate cancer (mCRPC).
 
Gustavo Rubio Romero
No Relationships to Disclose
 
Alana Weinstein
No Relationships to Disclose
 
Verena Friedl
No Relationships to Disclose
 
Adam Foye
No Relationships to Disclose
 
Denise Playdle
No Relationships to Disclose
 
Alexis Sabol
No Relationships to Disclose
 
Patricia Li
No Relationships to Disclose
 
Jiaoti Huang
Stock and Other Ownership Interests - KingMed Diagnostics; More Health; Optra SCAN
Honoraria - Abbvie
Consulting or Advisory Role - Gem Flower Healthcare
Research Funding - Fortis; Zenith Epigenetics
Travel, Accommodations, Expenses - Gem Flower Healthcare (I)
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Celgene; Dendreon; EMD Serono; Ferring; Janssen Oncology; Medivation/Astellas; Sanofi
Research Funding - Zenith Epigenetics
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Joshua M. Stuart
Stock and Other Ownership Interests - Five3 Genomics
Patents, Royalties, Other Intellectual Property - Pending Patent on CREB1 inhibition for treatment of metastatic prostate cancer.
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen
Consulting or Advisory Role - Fortis; Janssen Oncology
Research Funding - Janssen (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Janssen
 
Rahul Raj Aggarwal
Consulting or Advisory Role - AstraZeneca; Janssen
Research Funding - Abbvie; Cancer Targeted Technology; Gilead Sciences; Janssen; Merck; Novartis; Xynomic Pharma; Zenith Epigenetics
Travel, Accommodations, Expenses - Xynomic Pharma